A tech spin-out from the University of Manchester, which uses AI to curate masses of biomedical data to help scientists speed up research and development, has secured a £6.5m boost.
Biorelate has completed a Series A investment round led by Maven Capital Partners and YFM Equity Partners.
The Manchester Science Park company was founded in 2014 by chief executive Daniel Jamieson having previously worked at Pfizer.
